Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 71 out of 100. End-of-life care

Topic: Brain imaging, connectivity and assessment

As outlined in the original cohort profile,1 The Irish Longitudinal Study on Ageing (TILDA) is a prospective cohort study designed to provide an evidence base for addressing the challenges and opportunities associated with population ageing in Ireland. Hypertension affects over 60% of people aged 50 years and over in Ireland,14 and 18.9% of TILDA participants failed to stabilize blood pressure (BP) 30 s after standing.15 This impairment in blood pressure behaviour is associated with poor cognitive function,16 depression17 and unexplained falls,18 and is thought to be linked to impaired cerebral blood perfusion.19 However, it is important to understand which type of blood pressure behaviour (e.g. hypertension, hypotension, increased BP variability) causes the most serious damage to the brain. Compared with Wave 1, a higher proportion of Wave 3 participants completed any health assessment (81% versus 72%) and a home-based assessment (20% versus 14%), reflecting the importance of including this option for older and frailer participants.20,21 Response rates for each Wave of TILDA n/a, not available. Blood sample analytes: lipid profile, folate, Vitamin B12, Vitamin D, Vitamin E, associated with age-related sample hormone Included for a sub-study due to resource (i.e. accelerometers, of MRI Tests included in the TILDA health assessment at each health wave Indicate the wave in which data were collected (i.e. Blood sample analytes: lipid profile, folate, Vitamin B12, Vitamin D, Vitamin E, associated with age-related sample hormone Included for a sub-study due to resource (i.e. accelerometers, of MRI health assessment tests introduced in Wave 3 and the oral health assessment were provided to a subsample of participants due to resource (i.e. accelerometers, of MRI or in the or on an if in the brain of 6 of the or participants from participating in the of the health assessment tests introduced in Wave 3 and the oral health assessment were provided to a subsample of participants due to resource (i.e. accelerometers, of MRI or in the or on an if in the brain of 6 of the or participants from participating in the of the be participants have completed the cardiovascular tests during the health Participants aged years were to of brain changes with Research nurses informed participants the sub-study and provided an and participants were for MRI (see Table were subsequently contacted by to an and Participants were an and a consent TILDA to their general of a consent TILDA i

Key findings

Study details

How this study scored 71/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 3 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited left out, no data; Citations per year left out, no data; Impact for its field and year left out, no data; Cited by studies here left out, no data; Still being cited left out, no data; Senior author's track record left out, no data; Institution's track record left out, no data; Multi-centre collaboration left out, no data; Indexed in PubMed 2 of 2; Free to read 2 of 2. 41 of the 58 points it could be judged on, which is 71 of 100. Total 71 of 100.41 of the 58 points we could judge = 71 of 100

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for randomised / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multi-centre collaboration, so those were left out: it earned 41 of the 58 points we could judge it on, which is 71 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (International Journal of Epidemiology)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2018 — within 10 year(s) of the newest study here
Sample size 3 / 4 2,525 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited — / 7 No citation count (not found in OpenAlex) — left out of this score
Citations per year — / 5 No citation count or no year — left out of this score
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here — / 6 Not yet checked against this library's citation graph — left out of this score
Still being cited — / 4 No yearly citation counts — left out of this score
Senior author's track record — / 4 Senior author's record not available — left out of this score
Institution's track record — / 3 No institution listed in OpenAlex — left out of this score
Multi-centre collaboration — / 3 Institutions not listed — left out of this score
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 30124849)
Free to read 2 / 2 Free to read
Points 41 / 58 Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 41 of the 58 points we could judge it on is 71 out of 100.
Total 71 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Donoghue, O. A., McGarrigle, C. A., Foley, M. M., Fagan, A. J., Meaney, J. F., & Kenny, R. A. (2018). Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA). International Journal of Epidemiology. https://doi.org/10.1093/ije/dyy163

Vancouver

Donoghue OA, McGarrigle CA, Foley MM, Fagan AJ, Meaney JF, Kenny RA. Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA). International Journal of Epidemiology. 2018. doi:10.1093/ije/dyy163. PMID: 30124849.

BibTeX

@article{donoghue2018-30124849,
  author  = {Donoghue, Orna A. and McGarrigle, Christine Ann and Foley, Margaret M. and Fagan, Andrew J and Meaney, James F. and Kenny, Rose Anne},
  title   = {{Cohort Profile Update: The Irish Longitudinal Study on Ageing (TILDA)}},
  journal = {International Journal of Epidemiology},
  year    = {2018},
  doi     = {10.1093/ije/dyy163},
  pmid    = {30124849},
  url     = {https://doi.org/10.1093/ije/dyy163}
}

Related studies in End-of-life care

Also tagged “metabolic-syndrome”

304 studies in the library carry the topic tag “metabolic-syndrome”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 304 tagged studies.

Similar studies

More on End-of-life care

See all studies in End-of-life care →